0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Lung Cancer Liquid Biops - Global Market Insights and Sales Trends 2024
Published Date: November 2023
|
Report Code: QYRE-Auto-35Z1721
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Lung Cancer Liquid Biops Market Insights and Forecast to 2028
BUY CHAPTERS

Lung Cancer Liquid Biops - Global Market Insights and Sales Trends 2024

Code: QYRE-Auto-35Z1721
Report
November 2023
Pages:121
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Lung Cancer Liquid Biops - Market Size

The global Lung Cancer Liquid Biops market size is expected to reach US$ 1082 million by 2029, growing at a CAGR of 14.0% from 2023 to 2029.

Lung Cancer Liquid Biops -  Market

Lung Cancer Liquid Biops - Market

The market is mainly driven by the significant applications of Lung Cancer Liquid Biops in various end use industries. The expanding demands from the Hospitals and Clinics, Physicians'Office Laboratories and Clinical Diagnostic Laboratories,, are propelling Lung Cancer Liquid Biops market. Exosomes and RNA, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the CTCs and ctDNA segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Lung Cancer Liquid Biops market, driven by demand from China, the second largest economy with some signs of stabilising, the Lung Cancer Liquid Biops market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Lung Cancer Liquid Biops, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Lung Cancer Liquid Biops market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Lung Cancer Liquid Biops market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Lung Cancer Liquid Biops sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Lung Cancer Liquid Biops covered in this report include Biocept, EntroGen, Cynvenio Biosystems, Exosome Diagnostics, F. Hoffmann-La Roche, Clearbridge BioMedics, Bio-Rad Laboratories, Agena Bioscience and Cancer Genetics, etc.
The global Lung Cancer Liquid Biops market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Biocept
EntroGen
Cynvenio Biosystems
Exosome Diagnostics
F. Hoffmann-La Roche
Clearbridge BioMedics
Bio-Rad Laboratories
Agena Bioscience
Cancer Genetics
CellMax Life
Nateras
MedGenome
OncoDNA
Genomic Health
Trovagene
Fluxion Biosciences
Biodesix
Epic Sciences
Shuwen Biotech
Personal Genome Diagnostics
Predicine

Scope of Lung Cancer Liquid Biops - Market Report

Report Metric Details
Report Name Lung Cancer Liquid Biops - Market
Forecasted market size in 2029 US$ 1082 million
CAGR 14.0%
Forecasted years 2023 - 2029
Global Lung Cancer Liquid Biops market, by region:
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Lung Cancer Liquid Biops market, Segment by Type:
  • Exosomes and RNA
  • CTCs and ctDNA
Global Lung Cancer Liquid Biops market, by Application
  • Hospitals and Clinics
  • Physicians'Office Laboratories
  • Clinical Diagnostic Laboratories
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter Four: Detailed analysis of Lung Cancer Liquid Biops companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
  • Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
  • Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter Twelve: Research Finding/Conclusion

FAQ for this report

What is the Lung Cancer Liquid Biops - Market size in 2029?

Ans: The Lung Cancer Liquid Biops - Market size in 2029 will be US$ 1082 million.

What are the Application segmentation covered in the Lung Cancer Liquid Biops - Market report?

Ans: The Applications covered in the Lung Cancer Liquid Biops - Market report are Hospitals and Clinics, Physicians'Office Laboratories, Clinical Diagnostic Laboratories

What are the Type segmentation covered in the Lung Cancer Liquid Biops - Market report?

Ans: The Types covered in the Lung Cancer Liquid Biops - Market report are Exosomes and RNA, CTCs and ctDNA

1 Market Overview of Lung Cancer Liquid Biops
1.1 Lung Cancer Liquid Biops Market Overview
1.1.1 Lung Cancer Liquid Biops Product Scope
1.1.2 Lung Cancer Liquid Biops Market Status and Outlook
1.2 Global Lung Cancer Liquid Biops Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Lung Cancer Liquid Biops Market Size by Region (2018-2029)
1.4 Global Lung Cancer Liquid Biops Historic Market Size by Region (2018-2023)
1.5 Global Lung Cancer Liquid Biops Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Lung Cancer Liquid Biops Market Size (2018-2029)
1.6.1 North America Lung Cancer Liquid Biops Market Size (2018-2029)
1.6.2 Europe Lung Cancer Liquid Biops Market Size (2018-2029)
1.6.3 Asia-Pacific Lung Cancer Liquid Biops Market Size (2018-2029)
1.6.4 Latin America Lung Cancer Liquid Biops Market Size (2018-2029)
1.6.5 Middle East & Africa Lung Cancer Liquid Biops Market Size (2018-2029)
2 Lung Cancer Liquid Biops Market by Type
2.1 Introduction
2.1.1 Exosomes and RNA
2.1.2 CTCs and ctDNA
2.2 Global Lung Cancer Liquid Biops Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Lung Cancer Liquid Biops Historic Market Size by Type (2018-2023)
2.2.2 Global Lung Cancer Liquid Biops Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Lung Cancer Liquid Biops Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Lung Cancer Liquid Biops Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Lung Cancer Liquid Biops Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Lung Cancer Liquid Biops Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Lung Cancer Liquid Biops Revenue Breakdown by Type (2018-2029)
3 Lung Cancer Liquid Biops Market Overview by Application
3.1 Introduction
3.1.1 Hospitals and Clinics
3.1.2 Physicians'Office Laboratories
3.1.3 Clinical Diagnostic Laboratories
3.2 Global Lung Cancer Liquid Biops Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Lung Cancer Liquid Biops Historic Market Size by Application (2018-2023)
3.2.2 Global Lung Cancer Liquid Biops Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Lung Cancer Liquid Biops Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Lung Cancer Liquid Biops Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Lung Cancer Liquid Biops Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Lung Cancer Liquid Biops Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Lung Cancer Liquid Biops Revenue Breakdown by Application (2018-2029)
4 Lung Cancer Liquid Biops Competition Analysis by Players
4.1 Global Lung Cancer Liquid Biops Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Lung Cancer Liquid Biops as of 2022)
4.3 Date of Key Players Enter into Lung Cancer Liquid Biops Market
4.4 Global Top Players Lung Cancer Liquid Biops Headquarters and Area Served
4.5 Key Players Lung Cancer Liquid Biops Product Solution and Service
4.6 Competitive Status
4.6.1 Lung Cancer Liquid Biops Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Biocept
5.1.1 Biocept Profile
5.1.2 Biocept Main Business
5.1.3 Biocept Lung Cancer Liquid Biops Products, Services and Solutions
5.1.4 Biocept Lung Cancer Liquid Biops Revenue (US$ Million) & (2018-2023)
5.1.5 Biocept Recent Developments
5.2 EntroGen
5.2.1 EntroGen Profile
5.2.2 EntroGen Main Business
5.2.3 EntroGen Lung Cancer Liquid Biops Products, Services and Solutions
5.2.4 EntroGen Lung Cancer Liquid Biops Revenue (US$ Million) & (2018-2023)
5.2.5 EntroGen Recent Developments
5.3 Cynvenio Biosystems
5.3.1 Cynvenio Biosystems Profile
5.3.2 Cynvenio Biosystems Main Business
5.3.3 Cynvenio Biosystems Lung Cancer Liquid Biops Products, Services and Solutions
5.3.4 Cynvenio Biosystems Lung Cancer Liquid Biops Revenue (US$ Million) & (2018-2023)
5.3.5 Exosome Diagnostics Recent Developments
5.4 Exosome Diagnostics
5.4.1 Exosome Diagnostics Profile
5.4.2 Exosome Diagnostics Main Business
5.4.3 Exosome Diagnostics Lung Cancer Liquid Biops Products, Services and Solutions
5.4.4 Exosome Diagnostics Lung Cancer Liquid Biops Revenue (US$ Million) & (2018-2023)
5.4.5 Exosome Diagnostics Recent Developments
5.5 F. Hoffmann-La Roche
5.5.1 F. Hoffmann-La Roche Profile
5.5.2 F. Hoffmann-La Roche Main Business
5.5.3 F. Hoffmann-La Roche Lung Cancer Liquid Biops Products, Services and Solutions
5.5.4 F. Hoffmann-La Roche Lung Cancer Liquid Biops Revenue (US$ Million) & (2018-2023)
5.5.5 F. Hoffmann-La Roche Recent Developments
5.6 Clearbridge BioMedics
5.6.1 Clearbridge BioMedics Profile
5.6.2 Clearbridge BioMedics Main Business
5.6.3 Clearbridge BioMedics Lung Cancer Liquid Biops Products, Services and Solutions
5.6.4 Clearbridge BioMedics Lung Cancer Liquid Biops Revenue (US$ Million) & (2018-2023)
5.6.5 Clearbridge BioMedics Recent Developments
5.7 Bio-Rad Laboratories
5.7.1 Bio-Rad Laboratories Profile
5.7.2 Bio-Rad Laboratories Main Business
5.7.3 Bio-Rad Laboratories Lung Cancer Liquid Biops Products, Services and Solutions
5.7.4 Bio-Rad Laboratories Lung Cancer Liquid Biops Revenue (US$ Million) & (2018-2023)
5.7.5 Bio-Rad Laboratories Recent Developments
5.8 Agena Bioscience
5.8.1 Agena Bioscience Profile
5.8.2 Agena Bioscience Main Business
5.8.3 Agena Bioscience Lung Cancer Liquid Biops Products, Services and Solutions
5.8.4 Agena Bioscience Lung Cancer Liquid Biops Revenue (US$ Million) & (2018-2023)
5.8.5 Agena Bioscience Recent Developments
5.9 Cancer Genetics
5.9.1 Cancer Genetics Profile
5.9.2 Cancer Genetics Main Business
5.9.3 Cancer Genetics Lung Cancer Liquid Biops Products, Services and Solutions
5.9.4 Cancer Genetics Lung Cancer Liquid Biops Revenue (US$ Million) & (2018-2023)
5.9.5 Cancer Genetics Recent Developments
5.10 CellMax Life
5.10.1 CellMax Life Profile
5.10.2 CellMax Life Main Business
5.10.3 CellMax Life Lung Cancer Liquid Biops Products, Services and Solutions
5.10.4 CellMax Life Lung Cancer Liquid Biops Revenue (US$ Million) & (2018-2023)
5.10.5 CellMax Life Recent Developments
5.11 Nateras
5.11.1 Nateras Profile
5.11.2 Nateras Main Business
5.11.3 Nateras Lung Cancer Liquid Biops Products, Services and Solutions
5.11.4 Nateras Lung Cancer Liquid Biops Revenue (US$ Million) & (2018-2023)
5.11.5 Nateras Recent Developments
5.12 MedGenome
5.12.1 MedGenome Profile
5.12.2 MedGenome Main Business
5.12.3 MedGenome Lung Cancer Liquid Biops Products, Services and Solutions
5.12.4 MedGenome Lung Cancer Liquid Biops Revenue (US$ Million) & (2018-2023)
5.12.5 MedGenome Recent Developments
5.13 OncoDNA
5.13.1 OncoDNA Profile
5.13.2 OncoDNA Main Business
5.13.3 OncoDNA Lung Cancer Liquid Biops Products, Services and Solutions
5.13.4 OncoDNA Lung Cancer Liquid Biops Revenue (US$ Million) & (2018-2023)
5.13.5 OncoDNA Recent Developments
5.14 Genomic Health
5.14.1 Genomic Health Profile
5.14.2 Genomic Health Main Business
5.14.3 Genomic Health Lung Cancer Liquid Biops Products, Services and Solutions
5.14.4 Genomic Health Lung Cancer Liquid Biops Revenue (US$ Million) & (2018-2023)
5.14.5 Genomic Health Recent Developments
5.15 Trovagene
5.15.1 Trovagene Profile
5.15.2 Trovagene Main Business
5.15.3 Trovagene Lung Cancer Liquid Biops Products, Services and Solutions
5.15.4 Trovagene Lung Cancer Liquid Biops Revenue (US$ Million) & (2018-2023)
5.15.5 Trovagene Recent Developments
5.16 Fluxion Biosciences
5.16.1 Fluxion Biosciences Profile
5.16.2 Fluxion Biosciences Main Business
5.16.3 Fluxion Biosciences Lung Cancer Liquid Biops Products, Services and Solutions
5.16.4 Fluxion Biosciences Lung Cancer Liquid Biops Revenue (US$ Million) & (2018-2023)
5.16.5 Fluxion Biosciences Recent Developments
5.17 Biodesix
5.17.1 Biodesix Profile
5.17.2 Biodesix Main Business
5.17.3 Biodesix Lung Cancer Liquid Biops Products, Services and Solutions
5.17.4 Biodesix Lung Cancer Liquid Biops Revenue (US$ Million) & (2018-2023)
5.17.5 Biodesix Recent Developments
5.18 Epic Sciences
5.18.1 Epic Sciences Profile
5.18.2 Epic Sciences Main Business
5.18.3 Epic Sciences Lung Cancer Liquid Biops Products, Services and Solutions
5.18.4 Epic Sciences Lung Cancer Liquid Biops Revenue (US$ Million) & (2018-2023)
5.18.5 Epic Sciences Recent Developments
5.19 Shuwen Biotech
5.19.1 Shuwen Biotech Profile
5.19.2 Shuwen Biotech Main Business
5.19.3 Shuwen Biotech Lung Cancer Liquid Biops Products, Services and Solutions
5.19.4 Shuwen Biotech Lung Cancer Liquid Biops Revenue (US$ Million) & (2018-2023)
5.19.5 Shuwen Biotech Recent Developments
5.20 Personal Genome Diagnostics
5.20.1 Personal Genome Diagnostics Profile
5.20.2 Personal Genome Diagnostics Main Business
5.20.3 Personal Genome Diagnostics Lung Cancer Liquid Biops Products, Services and Solutions
5.20.4 Personal Genome Diagnostics Lung Cancer Liquid Biops Revenue (US$ Million) & (2018-2023)
5.20.5 Personal Genome Diagnostics Recent Developments
5.21 Predicine
5.21.1 Predicine Profile
5.21.2 Predicine Main Business
5.21.3 Predicine Lung Cancer Liquid Biops Products, Services and Solutions
5.21.4 Predicine Lung Cancer Liquid Biops Revenue (US$ Million) & (2018-2023)
5.21.5 Predicine Recent Developments
6 North America
6.1 North America Lung Cancer Liquid Biops Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Lung Cancer Liquid Biops Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Lung Cancer Liquid Biops Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Lung Cancer Liquid Biops Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Lung Cancer Liquid Biops Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Lung Cancer Liquid Biops Market Dynamics
11.1 Lung Cancer Liquid Biops Industry Trends
11.2 Lung Cancer Liquid Biops Market Drivers
11.3 Lung Cancer Liquid Biops Market Challenges
11.4 Lung Cancer Liquid Biops Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Tables
    Table 1. Global Market Lung Cancer Liquid Biops Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
    Table 2. Global Lung Cancer Liquid Biops Market Size by Region (2018-2023) & (US$ Million)
    Table 3. Global Lung Cancer Liquid Biops Market Size Share by Region (2018-2023)
    Table 4. Global Lung Cancer Liquid Biops Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 5. Global Lung Cancer Liquid Biops Forecasted Market Size Share by Region (2024-2029)
    Table 6. Global Lung Cancer Liquid Biops Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
    Table 7. Global Lung Cancer Liquid Biops Market Size by Type (2018-2023) & (US$ Million)
    Table 8. Global Lung Cancer Liquid Biops Revenue Market Share by Type (2018-2023)
    Table 9. Global Lung Cancer Liquid Biops Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 10. Global Lung Cancer Liquid Biops Revenue Market Share by Type (2024-2029)
    Table 11. North America Lung Cancer Liquid Biops Revenue by Type (2018-2023) & (US$ Million)
    Table 12. North America Lung Cancer Liquid Biops Revenue by Type (2024-2029) & (US$ Million)
    Table 13. Europe Lung Cancer Liquid Biops Revenue by Type (2018-2023) & (US$ Million)
    Table 14. Europe Lung Cancer Liquid Biops Revenue by Type (2024-2029) & (US$ Million)
    Table 15. Asia-Pacific Lung Cancer Liquid Biops Revenue by Type (2018-2023) & (US$ Million)
    Table 16. Asia-Pacific Lung Cancer Liquid Biops Revenue by Type (2024-2029) & (US$ Million)
    Table 17. Latin America Lung Cancer Liquid Biops Revenue by Type (2018-2023) & (US$ Million)
    Table 18. Latin America Lung Cancer Liquid Biops Revenue by Type (2024-2029) & (US$ Million)
    Table 19. Middle East and Africa Lung Cancer Liquid Biops Revenue by Type (2018-2023) & (US$ Million)
    Table 20. Middle East and Africa Lung Cancer Liquid Biops Revenue by Type (2024-2029) & (US$ Million)
    Table 21. Global Lung Cancer Liquid Biops Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
    Table 22. Global Lung Cancer Liquid Biops Market Size by Application (2018-2023) & (US$ Million)
    Table 23. Global Lung Cancer Liquid Biops Revenue Market Share by Application (2018-2023)
    Table 24. Global Lung Cancer Liquid Biops Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 25. Global Lung Cancer Liquid Biops Revenue Market Share by Application (2024-2029)
    Table 26. North America Lung Cancer Liquid Biops Revenue by Application (2018-2023) & (US$ Million)
    Table 27. North America Lung Cancer Liquid Biops Revenue by Application (2024-2029) & (US$ Million)
    Table 28. Europe Lung Cancer Liquid Biops Revenue by Application (2018-2023) & (US$ Million)
    Table 29. Europe Lung Cancer Liquid Biops Revenue by Application (2024-2029) & (US$ Million)
    Table 30. Asia-Pacific Lung Cancer Liquid Biops Revenue by Application (2018-2023) & (US$ Million)
    Table 31. Asia-Pacific Lung Cancer Liquid Biops Revenue by Application (2024-2029) & (US$ Million)
    Table 32. Latin America Lung Cancer Liquid Biops Revenue by Application (2018-2023) & (US$ Million)
    Table 33. Latin America Lung Cancer Liquid Biops Revenue by Application (2024-2029) & (US$ Million)
    Table 34. Middle East and Africa Lung Cancer Liquid Biops Revenue by Application (2018-2023) & (US$ Million)
    Table 35. Middle East and Africa Lung Cancer Liquid Biops Revenue by Application (2024-2029) & (US$ Million)
    Table 36. Global Lung Cancer Liquid Biops Revenue (US$ Million) by Players (2018-2023)
    Table 37. Global Lung Cancer Liquid Biops Revenue Market Share by Players (2018-2023)
    Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Lung Cancer Liquid Biops as of 2022)
    Table 39. Date of Key Players Enter into Lung Cancer Liquid Biops Market
    Table 40. Global Lung Cancer Liquid Biops Key Players Headquarters and Area Served
    Table 41. Lung Cancer Liquid Biops Product Solution and Service
    Table 42. Global Lung Cancer Liquid Biops Players Market Concentration Ratio (CR5 and HHI)
    Table 43. Mergers & Acquisitions, Expansion Plans
    Table 44. Biocept Basic Information List
    Table 45. Biocept Description and Business Overview
    Table 46. Biocept Lung Cancer Liquid Biops Products, Services and Solutions
    Table 47. Revenue (US$ Million) in Lung Cancer Liquid Biops Business of Biocept (2018-2023)
    Table 48. Biocept Recent Developments
    Table 49. EntroGen Basic Information List
    Table 50. EntroGen Description and Business Overview
    Table 51. EntroGen Lung Cancer Liquid Biops Products, Services and Solutions
    Table 52. Revenue (US$ Million) in Lung Cancer Liquid Biops Business of EntroGen (2018-2023)
    Table 53. EntroGen Recent Developments
    Table 54. Cynvenio Biosystems Basic Information List
    Table 55. Cynvenio Biosystems Description and Business Overview
    Table 56. Cynvenio Biosystems Lung Cancer Liquid Biops Products, Services and Solutions
    Table 57. Revenue (US$ Million) in Lung Cancer Liquid Biops Business of Cynvenio Biosystems (2018-2023)
    Table 58. Cynvenio Biosystems Recent Developments
    Table 59. Exosome Diagnostics Basic Information List
    Table 60. Exosome Diagnostics Description and Business Overview
    Table 61. Exosome Diagnostics Lung Cancer Liquid Biops Products, Services and Solutions
    Table 62. Revenue (US$ Million) in Lung Cancer Liquid Biops Business of Exosome Diagnostics (2018-2023)
    Table 63. Exosome Diagnostics Recent Developments
    Table 64. F. Hoffmann-La Roche Basic Information List
    Table 65. F. Hoffmann-La Roche Description and Business Overview
    Table 66. F. Hoffmann-La Roche Lung Cancer Liquid Biops Products, Services and Solutions
    Table 67. Revenue (US$ Million) in Lung Cancer Liquid Biops Business of F. Hoffmann-La Roche (2018-2023)
    Table 68. F. Hoffmann-La Roche Recent Developments
    Table 69. Clearbridge BioMedics Basic Information List
    Table 70. Clearbridge BioMedics Description and Business Overview
    Table 71. Clearbridge BioMedics Lung Cancer Liquid Biops Products, Services and Solutions
    Table 72. Revenue (US$ Million) in Lung Cancer Liquid Biops Business of Clearbridge BioMedics (2018-2023)
    Table 73. Clearbridge BioMedics Recent Developments
    Table 74. Bio-Rad Laboratories Basic Information List
    Table 75. Bio-Rad Laboratories Description and Business Overview
    Table 76. Bio-Rad Laboratories Lung Cancer Liquid Biops Products, Services and Solutions
    Table 77. Revenue (US$ Million) in Lung Cancer Liquid Biops Business of Bio-Rad Laboratories (2018-2023)
    Table 78. Bio-Rad Laboratories Recent Developments
    Table 79. Agena Bioscience Basic Information List
    Table 80. Agena Bioscience Description and Business Overview
    Table 81. Agena Bioscience Lung Cancer Liquid Biops Products, Services and Solutions
    Table 82. Revenue (US$ Million) in Lung Cancer Liquid Biops Business of Agena Bioscience (2018-2023)
    Table 83. Agena Bioscience Recent Developments
    Table 84. Cancer Genetics Basic Information List
    Table 85. Cancer Genetics Description and Business Overview
    Table 86. Cancer Genetics Lung Cancer Liquid Biops Products, Services and Solutions
    Table 87. Revenue (US$ Million) in Lung Cancer Liquid Biops Business of Cancer Genetics (2018-2023)
    Table 88. Cancer Genetics Recent Developments
    Table 89. CellMax Life Basic Information List
    Table 90. CellMax Life Description and Business Overview
    Table 91. CellMax Life Lung Cancer Liquid Biops Products, Services and Solutions
    Table 92. Revenue (US$ Million) in Lung Cancer Liquid Biops Business of CellMax Life (2018-2023)
    Table 93. CellMax Life Recent Developments
    Table 94. Nateras Basic Information List
    Table 95. Nateras Description and Business Overview
    Table 96. Nateras Lung Cancer Liquid Biops Products, Services and Solutions
    Table 97. Revenue (US$ Million) in Lung Cancer Liquid Biops Business of Nateras (2018-2023)
    Table 98. Nateras Recent Developments
    Table 99. MedGenome Basic Information List
    Table 100. MedGenome Description and Business Overview
    Table 101. MedGenome Lung Cancer Liquid Biops Products, Services and Solutions
    Table 102. Revenue (US$ Million) in Lung Cancer Liquid Biops Business of MedGenome (2018-2023)
    Table 103. MedGenome Recent Developments
    Table 104. OncoDNA Basic Information List
    Table 105. OncoDNA Description and Business Overview
    Table 106. OncoDNA Lung Cancer Liquid Biops Products, Services and Solutions
    Table 107. Revenue (US$ Million) in Lung Cancer Liquid Biops Business of OncoDNA (2018-2023)
    Table 108. OncoDNA Recent Developments
    Table 109. Genomic Health Basic Information List
    Table 110. Genomic Health Description and Business Overview
    Table 111. Genomic Health Lung Cancer Liquid Biops Products, Services and Solutions
    Table 112. Revenue (US$ Million) in Lung Cancer Liquid Biops Business of Genomic Health (2018-2023)
    Table 113. Genomic Health Recent Developments
    Table 114. Trovagene Basic Information List
    Table 115. Trovagene Description and Business Overview
    Table 116. Trovagene Lung Cancer Liquid Biops Products, Services and Solutions
    Table 117. Revenue (US$ Million) in Lung Cancer Liquid Biops Business of Trovagene (2018-2023)
    Table 118. Trovagene Recent Developments
    Table 119. Fluxion Biosciences Basic Information List
    Table 120. Fluxion Biosciences Description and Business Overview
    Table 121. Fluxion Biosciences Lung Cancer Liquid Biops Products, Services and Solutions
    Table 122. Revenue (US$ Million) in Lung Cancer Liquid Biops Business of Fluxion Biosciences (2018-2023)
    Table 123. Fluxion Biosciences Recent Developments
    Table 124. Biodesix Basic Information List
    Table 125. Biodesix Description and Business Overview
    Table 126. Biodesix Lung Cancer Liquid Biops Products, Services and Solutions
    Table 127. Revenue (US$ Million) in Lung Cancer Liquid Biops Business of Biodesix (2018-2023)
    Table 128. Biodesix Recent Developments
    Table 129. Epic Sciences Basic Information List
    Table 130. Epic Sciences Description and Business Overview
    Table 131. Epic Sciences Lung Cancer Liquid Biops Products, Services and Solutions
    Table 132. Revenue (US$ Million) in Lung Cancer Liquid Biops Business of Epic Sciences (2018-2023)
    Table 133. Epic Sciences Recent Developments
    Table 134. Shuwen Biotech Basic Information List
    Table 135. Shuwen Biotech Description and Business Overview
    Table 136. Shuwen Biotech Lung Cancer Liquid Biops Products, Services and Solutions
    Table 137. Revenue (US$ Million) in Lung Cancer Liquid Biops Business of Shuwen Biotech (2018-2023)
    Table 138. Shuwen Biotech Recent Developments
    Table 139. Personal Genome Diagnostics Basic Information List
    Table 140. Personal Genome Diagnostics Description and Business Overview
    Table 141. Personal Genome Diagnostics Lung Cancer Liquid Biops Products, Services and Solutions
    Table 142. Revenue (US$ Million) in Lung Cancer Liquid Biops Business of Personal Genome Diagnostics (2018-2023)
    Table 143. Personal Genome Diagnostics Recent Developments
    Table 144. Predicine Basic Information List
    Table 145. Predicine Description and Business Overview
    Table 146. Predicine Lung Cancer Liquid Biops Products, Services and Solutions
    Table 147. Revenue (US$ Million) in Lung Cancer Liquid Biops Business of Predicine (2018-2023)
    Table 148. Predicine Recent Developments
    Table 149. North America Lung Cancer Liquid Biops Market Size by Country (2018-2023) & (US$ Million)
    Table 150. North America Lung Cancer Liquid Biops Market Size by Country (2024-2029) & (US$ Million)
    Table 151. Europe Lung Cancer Liquid Biops Market Size by Country (2018-2023) & (US$ Million)
    Table 152. Europe Lung Cancer Liquid Biops Market Size by Country (2024-2029) & (US$ Million)
    Table 153. Asia-Pacific Lung Cancer Liquid Biops Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 154. Asia-Pacific Lung Cancer Liquid Biops Market Size by Region (2018-2023) & (US$ Million)
    Table 155. Asia-Pacific Lung Cancer Liquid Biops Market Size by Region (2024-2029) & (US$ Million)
    Table 156. Asia-Pacific Lung Cancer Liquid Biops Market Share by Region (2018-2023)
    Table 157. Asia-Pacific Lung Cancer Liquid Biops Market Share by Region (2024-2029)
    Table 158. Latin America Lung Cancer Liquid Biops Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 159. Latin America Lung Cancer Liquid Biops Market Size by Country (2018-2023) & (US$ Million)
    Table 160. Latin America Lung Cancer Liquid Biops Market Size by Country (2024-2029) & (US$ Million)
    Table 161. Middle East & Africa Lung Cancer Liquid Biops Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 162. Middle East & Africa Lung Cancer Liquid Biops Market Size by Country (2018-2023) & (US$ Million)
    Table 163. Middle East & Africa Lung Cancer Liquid Biops Market Size by Country (2024-2029) & (US$ Million)
    Table 164. Lung Cancer Liquid Biops Market Trends
    Table 165. Lung Cancer Liquid Biops Market Drivers
    Table 166. Lung Cancer Liquid Biops Market Challenges
    Table 167. Lung Cancer Liquid Biops Market Restraints
    Table 168. Research Programs/Design for This Report
    Table 169. Key Data Information from Secondary Sources
    Table 170. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Lung Cancer Liquid Biops Market Size Year-over-Year 2018-2029 & (US$ Million)
    Figure 2. Global Lung Cancer Liquid Biops Market Size (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global Lung Cancer Liquid Biops Market Share by Regions: 2022 VS 2029
    Figure 4. Global Lung Cancer Liquid Biops Forecasted Market Size Share by Region (2024-2029)
    Figure 5. North America Lung Cancer Liquid Biops Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 6. Europe Lung Cancer Liquid Biops Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 7. Asia-Pacific Lung Cancer Liquid Biops Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 8. Latin America Lung Cancer Liquid Biops Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 9. Middle East & Africa Lung Cancer Liquid Biops Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 10. Product Picture of Exosomes and RNA
    Figure 11. Global Exosomes and RNA Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 12. Product Picture of CTCs and ctDNA
    Figure 13. Global CTCs and ctDNA Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 14. Global Lung Cancer Liquid Biops Market Size Share by Type: 2022 & 2029
    Figure 15. North America Lung Cancer Liquid Biops Revenue Market Share by Type (2018-2029)
    Figure 16. Europe Lung Cancer Liquid Biops Revenue Market Share by Type (2018-2029)
    Figure 17. Asia-Pacific Lung Cancer Liquid Biops Revenue Market Share by Type (2018-2029)
    Figure 18. Latin America Lung Cancer Liquid Biops Revenue Market Share by Type (2018-2029)
    Figure 19. Middle East and Africa Lung Cancer Liquid Biops Revenue Market Share by Type (2018-2029)
    Figure 20. Hospitals and Clinics Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 21. Physicians'Office Laboratories Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 22. Clinical Diagnostic Laboratories Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 23. Global Lung Cancer Liquid Biops Market Size Share by Application: 2022 & 2029
    Figure 24. North America Lung Cancer Liquid Biops Revenue Market Share by Application (2018-2029)
    Figure 25. Europe Lung Cancer Liquid Biops Revenue Market Share by Application (2018-2029)
    Figure 26. Asia-Pacific Lung Cancer Liquid Biops Revenue Market Share by Application (2018-2029)
    Figure 27. Latin America Lung Cancer Liquid Biops Revenue Market Share by Application (2018-2029)
    Figure 28. Middle East and Africa Lung Cancer Liquid Biops Revenue Market Share by Application (2018-2029)
    Figure 29. Lung Cancer Liquid Biops Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 30. Global Top 5 and Top 10 Players Lung Cancer Liquid Biops Market Share in 2022
    Figure 31. North America Lung Cancer Liquid Biops Market Share by Country (2018-2029)
    Figure 32. U.S. Lung Cancer Liquid Biops Market Size (2018-2029) & (US$ Million)
    Figure 33. Canada Lung Cancer Liquid Biops Market Size (2018-2029) & (US$ Million)
    Figure 34. Germany Lung Cancer Liquid Biops Market Size (2018-2029) & (US$ Million)
    Figure 35. France Lung Cancer Liquid Biops Market Size (2018-2029) & (US$ Million)
    Figure 36. U.K. Lung Cancer Liquid Biops Market Size (2018-2029) & (US$ Million)
    Figure 37. Italy Lung Cancer Liquid Biops Market Size (2018-2029) & (US$ Million)
    Figure 38. Russia Lung Cancer Liquid Biops Market Size (2018-2029) & (US$ Million)
    Figure 39. Nordic Countries Lung Cancer Liquid Biops Market Size (2018-2029) & (US$ Million)
    Figure 40. Asia-Pacific Lung Cancer Liquid Biops Market Share by Region (2018-2029)
    Figure 41. China Lung Cancer Liquid Biops Market Size (2018-2029) & (US$ Million)
    Figure 42. Japan Lung Cancer Liquid Biops Market Size (2018-2029) & (US$ Million)
    Figure 43. South Korea Lung Cancer Liquid Biops Market Size (2018-2029) & (US$ Million)
    Figure 44. Southeast Asia Lung Cancer Liquid Biops Market Size (2018-2029) & (US$ Million)
    Figure 45. India Lung Cancer Liquid Biops Market Size (2018-2029) & (US$ Million)
    Figure 46. Australia Lung Cancer Liquid Biops Market Size (2018-2029) & (US$ Million)
    Figure 47. Latin America Lung Cancer Liquid Biops Market Share by Country (2018-2029)
    Figure 48. Mexico Lung Cancer Liquid Biops Market Size (2018-2029) & (US$ Million)
    Figure 49. Brazil Lung Cancer Liquid Biops Market Size (2018-2029) & (US$ Million)
    Figure 50. Middle East & Africa Lung Cancer Liquid Biops Market Share by Country (2018-2029)
    Figure 51. Turkey Lung Cancer Liquid Biops Market Size (2018-2029) & (US$ Million)
    Figure 52. Saudi Arabia Lung Cancer Liquid Biops Market Size (2018-2029) & (US$ Million)
    Figure 53. UAE Lung Cancer Liquid Biops Market Size (2018-2029) & (US$ Million)
    Figure 54. Bottom-up and Top-down Approaches for This Report
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3350

This license allows only one user to access the PDF.
Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS